From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
Compound
hMAO-A
hMAO-B
pIC50
ΔG (kcal/mol)
C53 53
4.00
− 35.10
8.49
− 38.10